Does isotretinoin (Accutane) cause dry eyes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Isotretinoin (Accutane) Cause Dry Eyes?

Yes, isotretinoin definitively causes dry eyes—this is an expected, nearly universal side effect that occurs in almost all patients treated with this medication. 1

Mechanism and Prevalence

Isotretinoin causes mucocutaneous dryness throughout the body by altering sebaceous gland function and reducing secretions from all epithelial surfaces. Almost all patients (approaching 100%) will experience some degree of mucocutaneous dryness, including xerophthalmia (dry eyes) 1. The ophthalmology literature specifically identifies systemic retinoids like isotretinoin as medications that exacerbate dry eye symptoms 2.

The dry eye effect is multifactorial:

  • Direct reduction in tear production
  • Meibomian gland dysfunction (demonstrated by 18.7-23.6% gland loss in studies) 3
  • Tear film instability with reduced break-up time 4, 3
  • Corneal nerve damage (reduced nerve fiber density and branching) 4
  • Conjunctivitis and other ocular surface complications 1

Clinical Severity

Recent research quantifies the impact:

  • 56.9% of current users report severe dry eye symptoms on validated OSDI scales 5
  • Schirmer test values drop significantly (5.7 mm vs 10.3 mm in controls) 4
  • Tear break-up time decreases dramatically (5.7 seconds vs 11.2 seconds in controls) 4
  • Symptoms include gritty sensation (66.4%), sore eyes (68.6%), and blurry vision (75.9%) 5

Risk Factors for Worse Outcomes

Contact lens wearers face substantially higher risk—contact lens use is associated with a 17.5-point increase in dry eye severity scores 5. Patients with pre-existing conditions that impair corneal wetting should be specifically counseled about these risks 1.

Each 10 mg increase in isotretinoin dose correlates with a 0.20-point rise in dry eye scores, confirming dose-dependency 5.

Management Algorithm

Before starting isotretinoin:

  • Identify high-risk patients (contact lens wearers, pre-existing dry eye, history of corneal disease)
  • Counsel ALL patients that dry eyes are expected, not optional
  • Consider prophylactic ocular lubricants for high-risk patients 1

During treatment:

  • Manage with liberal use of preservative-free artificial tears
  • Contact lens wearers should discontinue lens use or accept significantly increased symptoms
  • Consider omega-3 supplementation (1g/day reduces mucocutaneous side effects) 1
  • Refer to ophthalmology if symptoms are severe or vision is affected 6

Critical warning: Any patient experiencing visual difficulties should discontinue isotretinoin immediately and undergo ophthalmological examination 6. While dry eyes are common and expected, more serious complications like corneal opacities, decreased night vision, and keratitis can occur 1, 6.

Duration and Reversibility

The good news: dry eye symptoms typically resolve after discontinuing isotretinoin with standard treatment courses 7, 6. However, the damage accumulates with treatment duration—corneal nerve damage and meibomian gland loss worsen over time 4, 3. Symptoms improve gradually, with 51.2% reporting severe symptoms if stopped <2 months ago, dropping to 38.8% if stopped ≥2 months ago 5.

Common Pitfall

The most common error is failing to proactively counsel patients that dry eyes are an expected effect, not a rare complication. This leads to poor adherence and unnecessary treatment discontinuation when simple lubricant use would suffice. Set the expectation upfront and provide preventive strategies immediately.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.